Document Classification

Section Type: METHODS

Text: A total of 103 liver biopsy-proven chronic HCV patients with genotype 3, having alanine aminotransferase levels > 1. 2 x ULN and positive HCV-RNA were randomized into two groups : group I (n = 76 ; age, 43. 1 + / - 11. 4 years ; male/female, 67/9) received peg-IFN 1. 0 mug/kg/week + ribavirin 10. 6 mg/kg/day, while group II (n = 27 ; age, 37. 3 + / - 11. 6 years ; male/female, 21/6) received peg-IFN 1. 5 microg/kg/week + ribavirin 10. 6 mg/kg/day.